Lipase, protease and nuclease supply for pharmaceutical biocatalysis: route fit, impurity control, documentation and scale-up planning for API manufacturers, CDMOs and resellers. Request a quote.
Request pricingEnzymestech supplies process-ready enzyme inputs for pharmaceutical API manufacturers developing and scaling biocatalytic routes. We work with process chemists, CMC teams and procurement groups at API manufacturers, CDMOs and biotech companies, and with distributors and resellers who supply them, when they need reliable enzyme supply, clear documentation and practical technical alignment before plant introduction.
Our focus is route fit, impurity control, supply continuity and scale-up support for lipase, protease and nuclease-enabled processes. To start, send us the enzyme or transformation, the quantity you need and the delivery destination.
Wholesale and bulk supply, quote only. For manufacturers, resellers and biotech companies. In your inquiry, name the product or enzyme class, the quantity (trial amount and expected campaign volume) and the destination. Pack size, price and lead time are quoted per order. Request a quote
Biocatalysis is not qualified by catalog availability alone. Your enzyme input must match the route, solvent system, substrate profile, process window, downstream purification plan, and documentation expectations.
Enzymestech helps teams assess enzyme supply against the practical questions that determine whether a route can move forward:
Biocatalysis is valuable only when it improves the process as a whole. Typical use cases our buyers bring to us:
Lipases are used in pharmaceutical route design where selectivity, mild processing, and downstream simplification are central to the business case. Enzymestech supports lipase sourcing for resolution, esterification, transesterification, hydrolysis, and related chiral intermediate strategies. See lipase for API chiral resolution.
Typical buyer priorities include:
Protease-enabled processes can support selective bond formation or cleavage where conventional chemistry creates impurity, protection, or yield challenges. Enzymestech helps teams evaluate protease supply for route fit, process robustness, and scale continuity. See protease for pharma process development.
Common evaluation areas include:
Nucleases are used where nucleic acid reduction is part of a biologics, advanced therapy, or pharmaceutical manufacturing impurity control strategy. Enzymestech supports bulk nuclease supply with emphasis on process integration, documentation, and manufacturing continuity. See nuclease for pharmaceutical bioprocess support.
Qualification considerations include:
Route teams also ask about hydrolases for selective ester, amide and lactone steps; transaminases for chiral amines; ketoreductases and alcohol dehydrogenases for asymmetric alcohols; oxidases and oxygenases for selective oxidation; nitrilases and amidases for nitrile and amide pathways; and immobilized formats where reuse or simplified separation matters. Tell us the transformation and we will say whether we can support it.
Enzymestech is designed for buyers who need straight answers before a supplier is added to a route. We provide technical and commercial support that helps teams compare enzyme options, define supply requirements, and prepare for internal approval.
Our support can include:
We do not position an enzyme as route-ready without understanding the route context. The right input depends on chemistry, process constraints, quality expectations, and supply risk tolerance.
A promising enzymatic route can fail operationally if supply assumptions are vague. Clarifying availability, packaging, documentation and repeatability before the process is locked helps avoid late supplier qualification gaps, unexpected lot transitions and scale-up delays caused by unclear material availability.
For pharmaceutical API manufacturers, enzyme procurement is a technical sourcing decision. Price matters, but it does not replace continuity, documentation, and supplier responsiveness.
Enzymestech helps procurement teams clarify:
This reduces avoidable friction between process chemistry, quality, and sourcing teams. Our pharma process enzyme sourcing checklist sets out the full question list.
Enzymestech supports pharmaceutical buyers with documentation appropriate for supplier review and internal qualification workflows. Available documentation depends on the enzyme type, grade, and manufacturing source, and can be discussed during quote preparation.
Typical documentation requests may include:
To prepare a useful quote, Enzymestech may ask for non-confidential process context such as enzyme class, intended transformation, estimated campaign demand, preferred pack size, documentation needs, and target delivery location.
If the route is confidential, we can still begin with category-level requirements and procurement constraints.
Use the on-site request form to start a technical and commercial review. A Enzymestech representative will respond with availability, documentation options, and next-step questions for your process or procurement team.
What to put in your inquiry:



Tell us your application and volume — we reply with pricing and lead time.
We have received your message. We will reply by email.